4.5 Article

M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer

期刊

CANCER MANAGEMENT AND RESEARCH
卷 11, 期 -, 页码 6125-6138

出版社

DOVE MEDICAL PRESS LTD
DOI: 10.2147/CMAR.S199832

关键词

macrophage; microenvironment; polarization; non-small-cell lung cancer; prognosis; PD-L1

类别

资金

  1. National Science and Technology Major Project of the Ministry of Science and Technology of China [2017ZX09304025]
  2. National Natural Science Foundation of China [81602098, 31770963]
  3. Science and Technology Plan Project of Liaoning Province [2016007010, 2015020457]
  4. Key Research and Development Program of Shenyang [17-230-9-01]
  5. foundation for Selected Overseas Chinese Scholar

向作者/读者索取更多资源

Background: Lung cancer is the leading cause of cancer-related death worldwide. Although the macrophages can affect the development of tumor, the contribution of macrophages to the prognosis of non-small-cell lung cancer (NSCLC) is still controversial. Moreover, anti-PD-1 therapy can redirect macrophages from an M2 to an M1 phenotype, suggesting that tumor PD-L1 may affect the prognostic role of macrophages. Therefore, in this study, we aimed to display a macrophage landscape to clarify the function of macrophages, considering the localization and polarization of the macrophages, and evaluate the effect of M2 macrophages and tumor PD-L1 in combination on the prognosis of NSCLC. Methods: We performed multiplex quantitative immunofluorescence staining of pan-cytokeratin (CK), CD68, CD163, PD-L1, and DAPI on one tissue specimen simultaneously from 137 NSCLC patients. Results: M2 macrophages, involved marginM2 (M2 macrophages in tumor stroma), and centralM2 (M2 macrophages infiltrating into tumor islets) increased as the tumor stage increased. More macrophages were found in lung squamous cell carcinoma (LUSC) patients, patients with wild-type EGFR, and smokers than in patients with lung adenocarcinoma (LUAD), patients with EGFR mutations, and non-smokers. Infiltration of centralM2 was an independent prognostic factor of poor overall survival (OS) and disease-free survival (DFS) for NSCLC patients (P<0.05), which was superior to total macrophages and total M2 macrophages. Moreover, patients with centralM2(less)PD-L1(-) tumors showed the best OS and DFS, while the patients with centralM2(more)PD-L1(+) tumors showed the worst OS and DFS, and the two groups with centralM2(less)PD-L1(+) and centralM2(more)PD-L1(-) were in themiddle (P=0.002, 0.034, respectively). Conclusion: Tumor islet-infiltrating M2 macrophages influence the prognosis of NSCLC patients. The analysis of M2 macrophages and tumor PD-L1 in combination may enhance the accuracy of prognostic prediction. This study provides a new understanding of macrophages in the development of NSCLC through the analysis of macrophage landscape.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据